Cormorant Capital
North America, New York, United States, New York
Description
Cormorant Capital facilitates the growth of real estate-operator and owner clients by co-investing in select transactions.
Investor Profile
Cormorant Capital has backed more than 13 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 8 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series D rounds (top funding stages).
- Majority of deals are located in United States, Switzerland, China.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series B (31%)
- Series C (23%)
- Series D (15%)
- Series Unknown (15%)
- Private Equity (8%)
- Series A (8%)
Country Focus
- United States (85%)
- Switzerland (8%)
- China (8%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Life Science
- Therapeutics
- Health Diagnostics
- Personal Health
- Robotics
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
